Data-driven scientist | from confusion to understanding @HeyJosch@genomic.social

Deutschland
Joined May 2018
Joschka Hey retweeted
Ashish Goyal, Jens Bauer und Joschka Hey erhalten den diesjährigen #WaltraudLewenzPreis für ihre Arbeit über die Identifizierung von Neoantigenen, die von neu aktivierten Transkripten bei epigenetischen Therapien kodiert werden. Herzlichen Glückwunsch! 👏 @DKTK_
2
4
2
28
2,181
Trackplot: a fast and minimal dependency R script for epigenomic enrichment plots academic.oup.com/bioinformat… github.com/PoisonAlien/track…
2
16
58
5,798
Congratulations to all authors involved in this beautiful study about Juvenile Myelomonocytic Leukemia! I am pleased to have contributed to this work that not only demonstrates the oncofetal reprogramming of this childhood cancer, but also identifies therapeutic vulnerabilities.
Exciting findings in #childhoodcancer #oncofetal reprogramming of postnatal #stemcells and CD52 as a novel therapeutic target in #pediatric #leukemia New preprint from our lab by @mp_hartmann @MaxSchoenung @dblipka1 biorxiv.org/content/10.1101/…
1
10
797
Joschka Hey retweeted
Epigenetisch wirkende Medikamente ermöglichen, dass Bereiche des Erbguts abgelesen werden, die vorher blockiert waren. Das führt zur Bildung neuer mRNA und neuer Proteine, die das Immunsystem beim Erkennen von Krebszellen unterstützen könnten. @uktuebingen t1p.de/994hd
7
10
2,122
Although my time as a Postdoctoral Researcher at DKFZ has come to an end, I feel fortunate to have the opportunity to continue working in the same field as a Senior Bioinformatics Scientist at @Cytoreason. 6/7
1
93
Our main focus @Cytoreason is to utilize computational disease models to gain a better understanding of disease mechanisms, prioritize indications, and identify novel targets for various diseases. 7/7
1
91
One in 400 people among the general population – and 1 in 40 Ashkenazi Jews – is born with mutations in the BRCA genes that increase the risk of several cancer types. It's not surprising then that these mutations keep cancer researchers busy. (1/3)
3
10
2
29
5,830
Very happy that this is out! Thanks to the work of many passionate scientists from Academia, Industry and Clinics, to the generosity of #COPDpatients. High-resolution #transcriptomic and #epigenetic profiling ids novel #COPD regulators #Multiomics #humanLungFibroblasts
We completed the first whole genome #DNAmethylation profiles in #copd, revealing potential disease regulators 👇. High‐resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD embopress.org/doi/10.15252/e… #epigenetics, #wgbs 🧵
6
6
22
2,797
We completed the first whole genome #DNAmethylation profiles in #copd, revealing potential disease regulators 👇. High‐resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD embopress.org/doi/10.15252/e… #epigenetics, #wgbs 🧵
1
2
1
4
3,461
🔥📢Read the new study led by our very own Editor-in-Chief C. Plass @DKFZ and R. Scherz-Shourval @WeizmannScience on the epigenetic reprogramming of #TumorAssociatedMacrophages and their #DNAmethylation landscape 🔓➡️doi.org/10.1002/ijc.34364 #breastcancer, #TumorMicroenvironment
3
9
888
Thanks to all friends and collaborators who made this project possible! Congratulations @CoralHalperin, @mp_hartmann, @MayerShimrit, @MaxSchoenung, @dblipka1, @shouval, and Christoph Plass 5/n
1
6
If you haven’t seen our previous work on epigenetic reprogramming of the TME, check out our Cancer Research article on CAFs. aacrjournals.org/cancerres/a… 6/n
4